Feb 20 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT THERAPEUTICS AND TRIUMVIRA IMMUNOLOGICS TRIUMPHANTLY ANNOUNCE SECURED BRIDGE LOAN & LICENSE AGREEMENT
* KNIGHT THERAPEUTICS - $5 MILLION SECURED LOAN TERM 1 YEAR,WILL ENABLE TRIUMVIRA TO ACCELERATE ACTIVITIES TO BRING ITS INNOVATIVE LEAD PROGRAM INTO CLINIC